메뉴 건너뛰기




Volumn 13, Issue 5, 2005, Pages 923-930

Evolution of non-small cell lung cancer chemotherapy (Review)

Author keywords

Chemotherapy; NSCLC

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN;

EID: 25144511074     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.5.923     Document Type: Review
Times cited : (20)

References (59)
  • 1
    • 0015012375 scopus 로고
    • Carcinoma of the lung, a comparative series of 687 cases
    • Lince L and Lulu DJ: Carcinoma of the lung, a comparative series of 687 cases. Arch Surg 102: 103-107, 1971.
    • (1971) Arch Surg , vol.102 , pp. 103-107
    • Lince, L.1    Lulu, D.J.2
  • 2
    • 0015875563 scopus 로고
    • Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma
    • Host H: Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma. Cancer Chemother Rep 4: 161-164, 1973.
    • (1973) Cancer Chemother Rep , vol.4 , pp. 161-164
    • Host, H.1
  • 3
    • 84880323799 scopus 로고
    • Adriamycin in advanced bronchogenic carcinoma
    • Cotes FP, Takita H and Holland JF: Adriamycin in advanced bronchogenic carcinoma. Cancer 34: 161-164, 1973.
    • (1973) Cancer , vol.34 , pp. 161-164
    • Cotes, F.P.1    Takita, H.2    Holland, J.F.3
  • 4
    • 0020626047 scopus 로고
    • Adriamycin and Cytoxan in the treatment of inoperable lung cancer
    • Hoeltgen TM, McIntyre JM, Perlia CP, Lagakos SN, Stolbach LL and Bennett JM: Adriamycin and Cytoxan in the treatment of inoperable lung cancer. Cancer 51: 2005-2012, 1983. (Pubitemid 13092448)
    • (1983) Cancer , vol.51 , Issue.11 , pp. 2005-2012
    • Hoeltgen, T.M.1    MacIntyre, J.M.2    Perlia, C.P.3
  • 5
    • 0017662186 scopus 로고    scopus 로고
    • Combination chemotherapy of bronchogenic carcinoma, non-oat cell
    • Livingston RB: Combination chemotherapy of bronchogenic carcinoma, non-oat cell. Cancer Treat Rev 4: 153-165, 1997.
    • (1997) Cancer Treat Rev , vol.4 , pp. 153-165
    • Livingston, R.B.1
  • 6
    • 0018598523 scopus 로고
    • Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer
    • Casper ES, Grail RI, Kelsey DP, Critkovic E and Golbey RB: Phase II study of high dose cis-diammine-dichloroplatinum (II) in the treatment of non-small cell lung cancer. Cancer Treat Rep 63: 2107-2109, 1979. (Pubitemid 10138998)
    • (1979) Cancer Treatment Reports , vol.63 , Issue.11-12 , pp. 2107-2109
    • Casper, E.S.1    Gralla, R.J.2    Kelsen, D.P.3
  • 7
    • 0019492001 scopus 로고
    • Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules
    • Kelsen DT, Gralla RI, Casper ES, Critkovic E, Magill GB, Krown SE and Golby RB: Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung, randomized trial investigation in two dosage schedule. Ann Intern Med 95: 414-420, 1981. (Pubitemid 11007366)
    • (1981) Annals of Internal Medicine , vol.95 , Issue.4 , pp. 414-420
    • Gralla, R.J.1    Casper, E.S.2    Kelsen, D.P.3
  • 8
    • 0021962578 scopus 로고
    • Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V - A randomized comparison of four cisplatin-containing regimens
    • Ruckdeschel JC, Finkelstein DM, Mason BA and Creech RH: Chemotherapy for metastatic non-small cell bronchogenic carcinoma EST 2575, generation V-a randomized comparison of four cisplatin containing regimens. J Clin Oncol 3: 72-79, 1985. (Pubitemid 15187700)
    • (1985) Journal of Clinical Oncology , vol.3 , Issue.1 , pp. 72-79
    • Ruckdeschel, J.C.1    Finkelstein, D.M.2    Mason, B.A.3    Creech, R.H.4
  • 9
    • 0028843552 scopus 로고
    • Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
    • Non-Small Cell Lung Cancer Collaborative Groups
    • Non-Small Cell Lung Cancer Collaborative Groups: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311: 899-909, 1995.
    • (1995) BMJ , vol.311 , pp. 899-909
  • 10
    • 0026428122 scopus 로고
    • Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer study group
    • Weiden PL and Piantadosi S: Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer study group. J Natl Cancer Inst 83: 266-273, 1991.
    • (1991) J Natl Cancer Inst , vol.83 , pp. 266-273
    • Weiden, P.L.1    Piantadosi, S.2
  • 15
    • 0028154069 scopus 로고
    • Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicenter trial including 612 patients
    • Le Chevalier T, Brisgand D, Douillard JY, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 12: 360-367, 1994.
    • (1994) J Clin Oncol , vol.12 , pp. 360-367
    • Le Chevalier, T.1    Brisgand, D.2    Douillard, J.Y.3
  • 18
    • 0026010571 scopus 로고
    • Thoracic radiation therapy alone compared with combined chemotherapy for locally unresectable non-small cell lung cancer
    • Morton RF, Jett JR, McGinnis WL, et al: Thoracic radiation therapy alone compared with combined chemotherapy for locally unresectable non-small cell lung cancer. Ann Intern Med 115: 681-686, 1991.
    • (1991) Ann Intern Med , vol.115 , pp. 681-686
    • Morton, R.F.1    Jett, J.R.2    McGinnis, W.L.3
  • 27
    • 0033950286 scopus 로고    scopus 로고
    • Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an eastern cooperative oncology group trial
    • Bonomi P, Kim KM, Fairclough D, et al: Comparison of survival and quality of life in advanced non-small cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group Trial. J Clin Oncol 18: 623-631, 2000. (Pubitemid 30078543)
    • (2000) Journal of Clinical Oncology , vol.18 , Issue.3 , pp. 623-631
    • Bonomi, P.1    Kim, K.2    Fairclough, D.3    Cella, D.4    Kugler, J.5    Rowinsky, E.6    Jiroutek, M.7    Johnson, D.8
  • 28
    • 0033941848 scopus 로고    scopus 로고
    • Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: A phase II study of the european organization for research and treatment of cancer lung cancer cooperative group (EORTC 08955)
    • Van Zandwijk N, Smit EF, Kramer GWP, et al: Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage HIA N2 non-small cell lung cancer: a phase II study of the European Organisation for Research and Treatment of Cancer, Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol 18: 2658-2664, 2000. (Pubitemid 30463547)
    • (2000) Journal of Clinical Oncology , vol.18 , Issue.14 , pp. 2658-2664
    • Van Zandwijk, N.1    Smit, E.F.2    Kramer, G.W.P.3    Schramel, F.4    Gans, S.5    Festen, J.6    Termeer, A.7    Schlosser, N.J.J.8    Debruyne, C.9    Curran, D.10    Giaccone, G.11
  • 34
    • 0031462199 scopus 로고    scopus 로고
    • Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer
    • DOI 10.1023/A:1008219125746
    • Miller VA, Ng KK, Grant SC, et al: Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small cell lung cancer. Ann Oncol 8: 1269-1271, 1997. (Pubitemid 28164084)
    • (1997) Annals of Oncology , vol.8 , Issue.12 , pp. 1269-1271
    • Miller, V.A.1    Ng, K.R.2    Grant, S.C.3    Kindler, H.4    Pizzo, B.5    Heelan, R.T.6    Von Roemeling, R.7    Kris, M.G.8
  • 35
    • 0030823326 scopus 로고    scopus 로고
    • Paclitaxel (1-h infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: Results of a multicenter phase II trial
    • Greco A and Hainsworth JD: Paclitaxel (1-h infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial. Semin Oncol 24: 512-514, S12-S17, 1997.
    • (1997) Semin Oncol , vol.24
    • Greco, A.1    Hainsworth, J.D.2
  • 38
    • 0031205154 scopus 로고    scopus 로고
    • 2) plus carboplatin in non-small cell lung cancer: A randomized study
    • 2) plus carboplatin in non-small cell lung cancer: a randomized study. Semin Oncol 24: 12-30, S12-S33, 1997.
    • (1997) Semin Oncol , vol.24
    • Kosmidis, P.1    Milonakis, N.2    Fountzilas, G.3
  • 39
    • 0032761165 scopus 로고    scopus 로고
    • Combination chemotherapy with carboplatin, docetaxel, gemcitabine in advanced non-small cell lung cancer: A phase II study
    • Pectasides D, Aspropotamitis A, Halikia A, et al: Combination chemotherapy with carboplatin, docetaxel, gemcitabine in advanced non-small cell lung cancer: a phase II study. J Clin Oncol 17: 3816-3821, 1999.
    • (1999) J Clin Oncol , vol.17 , pp. 3816-3821
    • Pectasides, D.1    Aspropotamitis, A.2    Halikia, A.3
  • 41
    • 0030751045 scopus 로고    scopus 로고
    • Weekly paclitaxel in patients with advanced lung cancer: Preliminary data from a phase II trial
    • Akerly W, Choy H, Safran H, et al: Weekly paclitaxel in patients with advanced lung cancer: preliminary data from a phase II trial. Semin Oncol 24: S12-10-S12-13, 1997.
    • (1997) Semin Oncol , vol.24
    • Akerly, W.1    Choy, H.2    Safran, H.3
  • 42
    • 0030005778 scopus 로고    scopus 로고
    • Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer
    • Chang AY, de Vore R and Johnson D: Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer. Semin Oncol 23: S19-S21, 1996.
    • (1996) Semin Oncol , vol.23
    • Chang, A.Y.1    De Vore, R.2    Johnson, D.3
  • 49
    • 0029044996 scopus 로고
    • Summary of phase II data of docetaxel (taxotere) an active agent in the 1st and 2nd line treatment of advanced non-small cell lung cancer (NSCLC)
    • Fossella FV, Lee JS, Berille J, et al: Summary of phase II data of docetaxel (taxotere) an active agent in the 1st and 2nd line treatment of advanced non-small cell lung cancer (NSCLC). Semin Oncol 22: S22-S29, 1995.
    • (1995) Semin Oncol , vol.22
    • Fossella, F.V.1    Lee, J.S.2    Berille, J.3
  • 57
  • 58
    • 0028843552 scopus 로고
    • Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
    • Non-Small Cell Lung Cancer Collaborative Group
    • Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311: 899-909, 1991.
    • (1991) BMJ , vol.311 , pp. 899-909
  • 59
    • 9744260262 scopus 로고    scopus 로고
    • Twenty-five years of treating advanced NSCLC: What have we achieved?
    • Giaccone G: Twenty-five years of treating advanced NSCLC: what have we achieved? Ann Oncol 15: Siv81-Siv83, 2004.
    • (2004) Ann Oncol , vol.15
    • Giaccone, G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.